XVIPF (Xvivo Perfusion AB) Inventory Turnover: 0.29 (As of Mar. 2026)

What is Xvivo Perfusion AB Inventory Turnover?

Xvivo Perfusion AB XVIPF -1.32% 91 Inventory Turnover is 0.29 as of Mar. 2026. GuruFocus rates XVIPF with a GF Score™ of 91/100 and a GF Value™ of $42.07 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Xvivo Perfusion AB's Cost of Goods Sold for the three months ended in Mar. 2026 was $7.50 Mil. Xvivo Perfusion AB's Average Total Inventories for the quarter that ended in Mar. 2026 was $25.56 Mil. Xvivo Perfusion AB's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.29.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Xvivo Perfusion AB's Days Inventory for the three months ended in Mar. 2026 was 310.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Xvivo Perfusion AB's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.99.

Xvivo Perfusion AB (OTCPK:XVIPF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Xvivo Perfusion AB's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	25.5605	/	7.504	*	365 / 4
	=	310.82

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Xvivo Perfusion AB's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	25.5605	/	25.861
	=	0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Xvivo Perfusion AB Inventory Turnover Related Terms

Xvivo Perfusion AB Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Xvivo Perfusion AB's Inventory Turnover can be seen below:

Xvivo Perfusion AB Inventory Turnover Chart

Xvivo Perfusion AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.99

1.21

1.23

1.09

0.96

Xvivo Perfusion AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.27	0.19	0.17	0.23	0.29

91GF Score

Xvivo Perfusion AB XVIPF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Xvivo Perfusion AB Inventory Turnover Calculation

Xvivo Perfusion AB's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	22.884	/ (	(20.702	+	26.734)	/	2 )
=	22.884	/	23.718
=	0.96

Xvivo Perfusion AB's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	7.504	/ (	(26.734	+	24.387)	/	2 )
=	7.504	/	25.5605
=	0.29

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.29 mean?

Xvivo Perfusion AB (XVIPF) has a Inventory Turnover of 0.29 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Xvivo Perfusion AB and its competitors.

Is Xvivo Perfusion AB's Inventory Turnover too high?

Xvivo Perfusion AB's current Inventory Turnover is 0.29. Overall, Xvivo Perfusion AB has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Xvivo Perfusion AB's Inventory Turnover compare to ABT and SYK?

Xvivo Perfusion AB's Inventory Turnover of 0.29 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Xvivo Perfusion AB and its competitors. Xvivo Perfusion AB's current Inventory Turnover is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Xvivo Perfusion AB stock overvalued right now?

Based on GuruFocus' analysis, Xvivo Perfusion AB (XVIPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.07, compared to a current price of $29.00 — trading 31.1% below its estimated fair value. The current Inventory Turnover is 0.29. Xvivo Perfusion AB's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Xvivo Perfusion AB (XVIPF), the current Inventory Turnover is 0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xvivo Perfusion AB (XVIPF) Overvalued in 2026?

Based on GuruFocus' analysis, Xvivo Perfusion AB stock appears to be undervalued. The current stock price of $29.00 is trading 31.1% below its estimated GF Value™ of $42.07. GuruFocus considers Xvivo Perfusion AB to be Significantly Undervalued.

Key valuation signals for XVIPF:

Inventory Turnover: 0.29
GF Value™: $42.07 vs. price of $29.00 (31.1% below fair value)
GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the XVIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xvivo Perfusion AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:MCAP OSTO:VITR OSTO:NOLA B OSTO:CEVI OSTO:DVYSR OSTO:BICO OSTO:PAX OSTO:CRAD B OSTO:SEDANA OSTO:EPIS B ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges XVIVO:Sweden XVIVOs:UK 0RKL:UK 3XV:Germany

Address Gemenskapens gata 9, Molndal, SWE, SE-431 53

Website https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments, namely Thoracic: sales of lung and heart transplant products; Abdominal: sales of liver and kidney transplant products and perfusion services; and Services: revenue from the sale of services related to organ recovery, as well as digital products for communication and workflow management at transplantation clinics. The majority of revenue is derived from the Thoracic segment, and geographically, the majority is from the United States.

91GF Score

Get the complete analysis for XVIPF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.00

Price

$42.07

GF Value

View XVIPF Analysis

See Inventory Turnover data for all stocks →